Clinical Trial Update: ROTAHALER Device Optimization Study [Phase 1]

View source ↗

Summary

Phase 1 update showing completion of the ROTAHALER device optimization trial for asthma, sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ROTAHALER

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED